Cardiology Specialist Gets Pumped with $400 Million Cash Injection
New funding by Hong Kong Asia Medical Group comes less than a year after the company was rumored to be seeking a $500 million IPO Key takeaways: Hong Kong Asia…
RELATED ARTICLES
-
Cash-strapped Mirxes looks for lifeline in blood-based cancer detection
- BRIEF: Smithfield targets $400 million fundraising target in New York IPO
- IPO pitch puts BrainAurora’s earnings under the microscope
-
Cash-hungry Mabwell seeks financial tonic from Hong Kong investors
688062.SHG
-
Airdoc Tech enjoys healing properties of medical AI rally
2251.HK
- DeepRoute.ai gets $100 million charge from auto investor
